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Nicotine is one of the most addictive drugs abused by humans. Our laboratory and others have
demonstrated that nicotine decreases motility and induces seizure-like behavior in planarians
(pSLM, which are vigorous writhing and bending of the body) in a concentration-dependent
manner. Nicotine also induces withdrawal-like behaviors in these worms. Cotinine is the major
nicotine metabolite in humans, although it is not the final product of nicotine metabolism. Cotinine
is mostly inactive in vertebrate nervous systems and is currently being explored as a molecule
which possess most of nicotine’s beneficial effects and few of its undesirable ones. It is not known
whether cotinine is a product of nicotine metabolism in planarians. We found that cotinine by itself
does not seem to elicit any behavioral effects in planarians up to a concentration of 1 mM. We also
show that cotinine antagonizes the aforementioned nicotine-induced motility decrease and also
decreases the expression of nicotine-induced pSLMs in a concentration-dependent manner. Also
cotinine prevents the manifestation of some of the withdrawal-like behaviors induced by nicotine
in our experimental organism. Thus, we obtained evidence supporting that cotinine antagonizes
nicotine in this planarian species. Possible explanations include competitive binding of both
compounds at overlapping binding sites, at different nicotinic receptor subtypes, or maybe
allosteric interactions.
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1. Introduction
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Planarians are freshwater flatworms and are excellent model organisms in the field of
neurobiology, regeneration and pharmacology research. Their multipolar neurons are more
similar to vertebrates than to more evolved invertebrates, displaying a primitive bilateral
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brain and featuring many of the neurotransmitters found in vertebrates [1,2]. Recent
pharmacological research shows planarians being used as models for abused compounds
such as cocaine, amphetamines, and nicotine among others [3-6].
Nicotine is one of the most commonly abused substances in the world that leads to addiction
[7]. It is best-known as a component of tobacco products [8] and its main molecular target
are nicotinic acetylcholine receptors [9]. In planarians, nicotine displays an increase in
motility at lower concentrations, a decrease in motility at higher concentrations, and an
increase in planarian seizure like movements (pSLM) [10,11]. Planarians exposed to
nicotine for a period of about 24 hours display a series of withdrawal-like behaviors [5].

Author Manuscript

Cotinine is the major metabolite of nicotine in humans and both molecules are very similar
structurally, the only difference being a carbonyl group. Despite this close structural
similarity, cotinine does not display the same effects as nicotine [12]. For example, upon
consumption of tobacco products, cotinine is found in the blood at higher levels than
nicotine and is metabolized at a slower rate. Moreover, cotinine is not the final step in
nicotine metabolism. In bovine adrenal chromafin cells, cotinine has shown to desensitize
nicotinic responses and inhibit protein kinase C activation [13,14]). In rats, cotinine was
found to have a binding affinity approximately three orders of magnitude lower than nicotine
[15]. To the best of our knowledge, this is the first work describing nicotine-cotinine
interactions in planarians. This work will contribute to the characterization of nicotinic
cholinergic systems in our experimental organism.

2. Materials and methods
Author Manuscript

Brown planarians (Girardia tigrina) were purchased from Ward’s (Rochester, NY). Cotinine
and nicotine were purchased from Tocris, (Bristol, UK). Other laboratory materials and
supplies were purchased from Fisher scientific (Suwanee, GA) or Sigma-Aldrich (St. Louis,
MO). The graphs/statistical analyses were done with the Prism software package (GraphPad
Inc., San Diego, CA).
Planarians were transferred to artificial pond water (APW, NaCl, 6mM; NaHCO3, 0.1 mM;
CaCl2, 0.6 mM) upon arrival, and were acclimated to these conditions for at least 24 hours
before use. All planarians received were used within three weeks of arrival. The APW was
changed at least once every day except during weekends and always before experiments. All
petri dishes, ceramic wells, graduated cylinders and microcentrifuge tubes were rinsed with
APW before experiments. All experiments were performed at room temperature in APW.
All reagents were prepared as APW solutions.
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Planarian motility and seizure like movements were studied using established laboratory
protocols [11,16,17]. To determine the planarian motility, a planarian (1.0-1.5 cm long) was
placed in a clear APW-rinsed 6 cm polystyrene petri dish and placed over a 1cm2 grid. 5mL
of experimental solutions (APW, nicotine 10-1000 μM, cotinine 10- 1000 μM, and
combination 10-1000 μM nicotine/1000 μM cotinine) were added and the cumulative
crosses were counted over a period of 8 minutes [16]. For pSLM, measurements a planarian
was placed in an APW rinsed ceramic well. The ceramic well was filled with experimental
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solution (APW, nicotine 10-1000μM, cotinine 10-1000 μM, combination nicotine 1000 μM/
cotinine 100-1000 μM) and pSLMs were observed and counted over a period of 10 minutes.
The use of these ceramic containers allowed us to minimize the amount of reagents used.
Withdrawal-like behavior experiments were adapted from established protocols [5].
Planarians were placed individually in 1.5 mL microcentrifuge tubes with experimental
solutions of either APW, 100 μM nicotine, 100 μM cotinine, or a combination of 100 μM
nicotine/100 μM cotinine and were closed for 21-26 hours. After this time, planarians were
transferred to a ceramic well with APW in the absence of any other compounds and
measured for the following movements: ‘headbop’ (bobbing head while moving),
‘corkscrew’ (spiral movement while in motion), ‘tailtwist’(twisting of the tail), ‘headswing’
(head movement while tail is anchored), and ‘squirming’(jerking or scrunching of the body)
as described in [4]. Measurements occurred at three time periods, 0-5 minutes, 30-35
minutes, and 60-65 minutes.

Author Manuscript

3. Results
When measuring motility of the planarians exposed to 10 μM-1000 μM nicotine, they
experienced a concentration-dependent decrease in velocity (Figure 1), with an IC50 of 162
μM. However, when exposed to the same amount of cotinine (10 μM-1000 μM), no
significant motility decrease was observed. On the other hand, the presence of 1 mM
cotinine significantly shifted the apparent nicotine IC50 to 490 μM, a threefold difference
(Figure 1, p-value = 0.002, F-test).
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When planarians were exposed to nicotine in solution with concentrations ranging from 10
μM-2000 μM, they experienced a concentration-dependent increase in pSLMs (For an
example of such a concentration-response curve please see [18]). Cotinine, however, at
ranges from 10 μM-1000 μM, caused no changes in pSLM when compared with controls of
APW (data not shown). However, when the worms were co-exposed to a single
concentration of nicotine (1 mM) concurrently with various concentrations of cotinine (100
μM - 1 mM), nicotine displayed a significant concentration-dependent cotinine-induced
decrease in pSLMs (Figure 2).
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Planarians exposed to nicotine for a period close to 24 hours expressed withdrawal-like
behaviors, while those exposed to cotinine did not show any significant difference from
control worms. However, when nicotine and cotinine were combined (Figure 3) although a
qualitative decrease in the number of withdrawal-like behaviors were observed in some
cases, these were not statistically significant as plotted. On the other hand, when the data
was expressed, not as the number of events over time but rather, as the cumulative number of
events in the presence of the compound combinations, we were able to observe a significant
cotinine-induced decrease in some of the nicotine-induced withdrawal behaviors (Figure 4).

4. Discussion
Our experiments show several intriguing results in regards to nicotine/cotinine interaction in
planarians. The first point is that these results confirm previous experiments in planarians
using nicotine; namely, our results confirm that nicotine decreases motility, induces seizure-
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like movements, and still causes withdrawal-like behavioral effects after an approximately
24 hour incubation [4,5,10,11]. Second, cotinine, a nicotine metabolite, elicits no
statistically significant behavioral changes in our experimental organism, despite it being
very structurally similar to nicotine.
The third and most important finding however, is that when these two compounds are in the
same solution, the motility decrease and pSLM behaviors are significantly reduced when
compared to the exposure of nicotine alone (Figures 1,2) which mimic acute exposure to
nicotine. Cotinine also reduces the expression of three out of five nicotine-induced
withdrawal-like behaviors that mimic chronic nicotine exposure (Figures 3,4).
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Moreover, our work suggests that the molecular targets or maybe the mechanisms of
nicotine that induce motility decrease, pSLMs and withdrawal-like behaviors may be
independent of each other. Several points support this assertion. Cotinine does not
antagonize all the nicotine-induced behaviors in all experiments (see Figures 3,4;
withdrawal-like behaviors). In contrast, cotinine antagonizes both the motility decrease and
the pSLMs induced by nicotine, albeit with different potencies. For example, in the motility
studies, 1 mM cotinine is able to reduce the apparent nicotine potency threefold (Figure 1),
while at the same concentration cotinine is only able to reduce nicotine’s potency to induce
pSLMs by approximately 50 % (Figure 2).
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We speculate that cotinine is binding to the same or overlapping binding site of nicotine or
that cotinine is binding at an allosteric site changing the conformation of the receptor target.
Moreover, it is known that there is a variety of nicotinic acetylcholine receptors described in
vertebrates. Several of these have also been identified in certain planarian species [19,20]. It
is quite possible that different types of nicotinic receptors may modulate different behavioral
responses. Future experiments will include work using other cholinergic compounds to
elucidate the various mechanisms through which nicotine induces its planarian-related
behaviors.
Author’s contributions: D.J.B. wrote the first version of this manuscript and contributed to
the design and performance of the experiments and to the data analyses/interpretation. M.T.,
D.L.B., S.D., and E.M. contributed to the performance of the experiments and to the data
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Highlights
•

Our experimental animal is the planarian.

•

Cotinine antagonizes the nicotine-induced motility decrease.

•

Cotinine antagonizes the nicotine-induced seizure-like movements.

•

Cotinine antagonizes three types of nicotine-induced withdrawal
behaviors.
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Concentration-response curve of the fraction of control of planarian motility vs. either
nicotine alone, cotinine alone or the combination of both. Cotitine did not reduce planarian
motility, while nicotine did, in agreement to previous work. Moreover, the presence of
cotinine significantly shifted the apparent IC50 of nicotine threefoldwise to the right (162
μM to 490 μM, p = 0.0002, see text). The symbols represent the average response of at least
six worms. The data points were fit to the equation: Fraction of control = Bottom + (TopBottom) / (1+10(log M Nicotine - LogIC50)). The error bars represent the standard error of the
mean.
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Figure 2.
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Cotinine antagonizes the induction of pSMLs by nicotine in a concentration-dependent
manner. The error bars represent the standard error of the mean. The bars are different from
each other by ANOVA (P < 0.0001), and each bar represents the average of 4-16 worms. The
individual p-values between bars shown above were calculated by the non-parametric MannWhitney test.
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Figure 3.
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Cotinine fails to antagonize the induction of withdrawal-like behaviors induced by nicotine
as a function of time, as indicated. The error bars represent the standard error of the mean.
Each symbol represents the average of 4 to 8 worms. In all behaviors, the results (control,
nicotine, cotinine, and nicotine/cotinine, as indicated) were not statistically significant from
each other (Kuskal-Wallis test followed by a Dunns post-test). Whenever a symbol is not
visible it means that it’s being overlapped by other symbols.
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Alternate analysis of the data in Figure 3. Cotinine antagonizes three out of the five nicotineor cotinine-induced, withdrawal-like behaviors when analyzing them based on the
cumulative number of events over the 65 minutes of each experiment. In none of the five
cases cotinine induced the withdrawal-like behaviors, determined by comparing it to the
control (APW; NS = Not Significant). Moreover, with the exception of the corkscrew and
tail twist behaviors, the consistently observed pattern was: Cotinine vs Control = NS;
Nicotine vs Control = Significant, Nicotine/Cotinine vs Control = back to NS. Thus, we
interpret this data as the cotinine “alleviation” of the nicotine-induced withdrawal behaviors
in three out of the five observed behaviors. P values were obtained by two-tailed, unpaired ttests. The error bars represent the standard error of the mean. Each bar represents the
average of 4 to 8 worms.
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